Home/Filings/4/0001179110-18-002112
4//SEC Filing

Leicher Bruce 4

Accession 0001179110-18-002112

CIK 0001235010other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 6:09 PM ET

Size

8.4 KB

Accession

0001179110-18-002112

Insider Transaction Report

Form 4
Period: 2018-02-12
Leicher Bruce
SVP & General Counsel
Transactions
  • Sale

    Common Stock

    2018-02-12$16.20/sh309$5,006176,210 total
  • Sale

    Common Stock

    2018-02-14$15.16/sh4,639$70,327171,571 total
  • Award

    Restricted Stock Units

    2018-02-1245,00045,000 total
    Common Stock (45,000 underlying)
Footnotes (3)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
  • [F3]Subject to certain criteria, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date.

Issuer

MOMENTA PHARMACEUTICALS INC

CIK 0001235010

Entity typeother

Related Parties

1
  • filerCIK 0001345695

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:09 PM ET
Size
8.4 KB